Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : utha's creative thread. All utha's friends and enemies welco -- Ignore unavailable to you. Want to Upgrade?

To: uthabros who wrote (80)	12/7/2000 10:57:35 AM
From: freshears	Read Replies (1) \| Respond to of 92

Utha, after having attended DNAP's open house last weekend and talked to all of the principals involved, here's my response to a few of the points made in your friend's DNAP report: 1. DNAP is in Sarasota because there are so many retirees there who are willing to have their DNA tested. You probably couldn't find a better place to do population studies on adverse drug reactions, the results of which will become DNAP's core business. 2. Whatever TBF's past record, Carl Smith has nothing to do with the day-to-day operations of the company. Dr. Tony Frudakis is CEO. I don't believe your friend's assertions about Tony being involved in any pump and dumps. You'll need to show me proof. Tony's past record as a scientist is nothing less than stellar and includes finding the antigens that propelled Corixa into the big time with the pharmaceuticals. 3. Orchid paid DNAP $350K for first right of refusal on any DNAP products, and DNAP gets to set the price. 4. Orchids' SNIP $750K machine is up and running in the new facility, which will be ready for complete occupancy by the end of December. I know, I've been there. 5. Your friend's report seems to be filled with nothing but innuendo and unfounded suggestions. I suggest you go to the DNAP board on RB and do some real DD.